AEMD (aethlonmedical.com) צמיחת רווח נקי למניה השנה

Aethlon Medical (AEMD) delegates the production of cartridges to external contractors, which impacts the shift in earnings per share compared to last year. Revenue stability is increasing due to the implementation of blood purification systems in clinics, while environmental control is based on RoHS. The value of 87.70 shapes the current metric, capturing the company's yield dynamics against the backdrop of external market conditions.

This indicator serves as an early warning tool for a long-term trend reversal by monitoring earnings per share (EPS) dynamics for Aethlon Medical (AEMD). By analyzing the magnitude of the annual change in EPS, the investor tracks the percentage deviation of the current earnings figure from the value of the same period last year. Growth in this metric will confirm the effectiveness of the Hemopurifier system's commercialization, reflecting the successful implementation of blood filtration into intensive care.